Literature DB >> 19288139

Change in C1q deposition in C1q nephropathy.

Kazunari Kaneko, Masafumi Hasui, Ken Hatae, Hidenori So, Ritsuko Katafuchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19288139     DOI： 10.1007/s00467-009-1164-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  5 in total

1.  C1q nephropathy: a pediatric clinicopathologic study.

Authors:  S S Iskandar; M C Browning; W B Lorentz
Journal:  Am J Kidney Dis       Date:  1991-10       Impact factor: 8.860

2.  C1Q nephropathy in children.

Authors:  Tanja Kersnik Levart; Rajko B Kenda; Mojca Avgustin Cavić; Dusan Ferluga; Anastazija Hvala; Alenka Vizjak
Journal:  Pediatr Nephrol       Date:  2005-10-25       Impact factor: 3.714

3.  C1q nephropathy: features at presentation and outcome.

Authors:  Keith K Lau; Lillian W Gaber; Noel M Delos Santos; Robert J Wyatt
Journal:  Pediatr Nephrol       Date:  2005-04-13       Impact factor: 3.714

4.  A single-center study of C1q nephropathy in children.

Authors:  Isabel Roberti; Noosha Baqi; Shefali Vyas; Dae Un Kim
Journal:  Pediatr Nephrol       Date:  2008-08-08       Impact factor: 3.714

5.  Clinicopathologic correlation of C1q nephropathy in children.

Authors:  Yuko Fukuma; Satoshi Hisano; Yoshie Segawa; Kazuhiko Niimi; Noboru Tsuru; Yoshitsugu Kaku; Ken Hatae; Yasuhiro Kiyoshi; Akihisa Mitsudome; Hiroshi Iwasaki
Journal:  Am J Kidney Dis       Date:  2006-03       Impact factor: 8.860
  5 in total
  1 in total

1.  Resolution of C1q deposition but not of the clinical nephrotic syndrome after immunomodulating therapy in focal sclerosis.

Authors:  Tibor Tibor Fülöp; Éva Csongrádi; Anna A Lerant; Matthew Lewin; Jack R Lewin
Journal:  J Nephropathol       Date:  2015-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.